Study of antidepressants finds modest effect on QT prolongation
Reckitt blocked by FDA on buprenorphine, faces FTC inquiry
SSRIs and tramadol: Possible link to serotonin syndrome
Orexin receptor antagonist effective for insomnia
Antipsychotics' receptor profiles linked to stroke risk
FDA Update: FDA offers new guidance on developing drugs for Alzheimer's disease
Common genetic variation and antidepressant efficacy